MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,024 | -37.3% | 7,014 | -0.8% | 0.01% | -28.6% |
| Q2 2023 | $1,633 | +1.8% | 7,068 | +6.8% | 0.01% | -12.5% |
| Q1 2023 | $1,604 | -56.0% | 6,620 | -47.3% | 0.01% | -57.9% |
| Q4 2022 | $3,646 | -99.3% | 12,560 | +60.0% | 0.02% | +533.3% |
| Q3 2022 | $510,000 | -8.1% | 7,850 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $555,000 | -32.2% | 7,750 | -7.2% | 0.00% | -25.0% |
| Q1 2022 | $819,000 | +31.5% | 8,350 | +13.6% | 0.00% | +33.3% |
| Q4 2021 | $623,000 | -6.5% | 7,350 | -12.0% | 0.00% | 0.0% |
| Q3 2021 | $666,000 | -18.1% | 8,350 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $813,000 | -59.3% | 8,350 | -51.1% | 0.00% | -63.6% |
| Q1 2021 | $1,996,000 | +11.8% | 17,060 | +6.2% | 0.01% | +10.0% |
| Q4 2020 | $1,785,000 | -4.0% | 16,060 | +2.6% | 0.01% | -23.1% |
| Q3 2020 | $1,859,000 | +5.5% | 15,660 | +0.6% | 0.01% | 0.0% |
| Q2 2020 | $1,762,000 | +77.6% | 15,560 | +4.7% | 0.01% | +30.0% |
| Q1 2020 | $992,000 | -26.5% | 14,860 | +0.3% | 0.01% | 0.0% |
| Q4 2019 | $1,349,000 | +7.1% | 14,810 | +1.4% | 0.01% | -9.1% |
| Q3 2019 | $1,259,000 | -18.3% | 14,600 | -0.7% | 0.01% | -21.4% |
| Q2 2019 | $1,541,000 | -14.6% | 14,700 | +2.1% | 0.01% | -17.6% |
| Q1 2019 | $1,804,000 | +26.1% | 14,400 | +13.4% | 0.02% | +6.2% |
| Q4 2018 | $1,431,000 | +234.3% | 12,698 | +535.5% | 0.02% | +300.0% |
| Q3 2018 | $428,000 | -49.1% | 1,998 | -33.6% | 0.00% | -55.6% |
| Q2 2018 | $841,000 | -35.0% | 3,007 | -72.9% | 0.01% | -40.0% |
| Q1 2018 | $1,294,000 | +60.9% | 11,082 | +26.6% | 0.02% | +66.7% |
| Q4 2017 | $804,000 | +127.8% | 8,757 | +11.5% | 0.01% | +80.0% |
| Q3 2017 | $353,000 | – | 7,857 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |